[18F]FP-R01-MG

N/A

Report date: 2025/11/21 17:15:44
NME

Base Information

Drug Name[18F]FP-R01-MG
Drug Alias Nameanti-integrin alpha-v-beta6 cystine knot PET tracer[18F]FP-R01-MG-F2[18F]FP-R01-MG
ClassificationSmall moleculesDiagnostic agent (In vivo)Radiation-emitting products > Radioactive diagnostic agent +[5] 
Mechanisms of ActionIntegrin alpha-V/beta-6 antagonists
TargetsIntegrin alpha-V/beta-6
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Brain metastasesIdiopathic Pulmonary Fibrosis +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesChinese Academy Of Medical Science & Peking Union Medical CollegeStanford UniversityPliant Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesThe University Of California DavisPliant Therapeutics IncStanford University
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Brain metastasesIdiopathic Pulmonary Fibrosis +[7] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A